Search Press releases Keywords From To 31 Aug 2020 Phase 3 data on VIMPAT[®] (lacosamide) in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry Read More 28 Aug 2020 Disposals of own shares Read More 21 Aug 2020 Disposals of own shares Read More 10 Aug 2020 Acquisitions and disposals of own shares Read More 5 Aug 2020 CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum Read More 30 Jul 2020 Acquisitions and disposals of own shares Read More Pagination First page Previous page Previous … Page 54 Page 55 Page 56 Page 57 Current page 58 Page 59 Page 60 Page 61 Page 62 … Page 58 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
